The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.
This section includes selected Alkermes abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.
Roger S. McIntyre, MD,1,2 Tarrah Holliday, ARNP, PMHNP-BC,3 Chelsie Monroe, MSN, APN, PMHNP-BC,4 Mark S. Todtenkopf, PhD,5 James A. McGrory, PhD,5 Craig Chepke, MD, DFAPA6,7
1University of Toronto, Department of Psychiatry, Toronto, ON, Canada; 2University of Toronto, Department of Pharmacology and Toxicology, Toronto, ON, Canada; 3Resilient Health Services, Des Moines, IA, USA; 4Balanced Mental Wellness, Littleton, CO, USA; 5Alkermes, Inc., Waltham, MA, USA; 6Excel Psychiatric Associates, P.A., Huntersville, NC, USA; 7Atrium Health, Charlotte, NC, USA
